Cargando…

Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program

Background: today’s standard quality control methods used to control the protein composition of inactivated influenza vaccines only take into account a few key reference components. They do not allow for thorough characterization of protein compositions. As a result, observation of unpredictable var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarasov, Mikhail, Shanko, Andrei, Kordyukova, Larisa, Katlinski, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564049/ https://www.ncbi.nlm.nih.gov/pubmed/32872645 http://dx.doi.org/10.3390/vaccines8030488

Ejemplares similares

Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program
por: Shanko, Andrei, et al.
Publicado: (2020)

Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine
por: Kordyukova, Larisa V., et al.
Publicado: (2023)

COVID-19: Myths and Reality
por: Kordyukova, Larisa V., et al.
Publicado: (2021)

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories
por: Rudenko, Larisa, et al.
Publicado: (2016)

Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India
por: Dar, Lalit, et al.
Publicado: (2023)

The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Two Cytoplasmic Acylation Sites and an Adjacent Hydrophobic Residue, but No Other Conserved Amino Acids in the Cytoplasmic Tail of HA from Influenza A Virus Are Crucial for Virus Replication
por: Siche, Stefanie, et al.
Publicado: (2015)

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
por: Shcherbik, Svetlana, et al.
Publicado: (2015)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
por: Rudenko, Larisa, et al.
Publicado: (2015)

Characterization of a whole, inactivated influenza (H5N1) vaccine
por: Tada, Yoshikazu
Publicado: (2008)

CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
por: Martel, Cyril Jean-Marie, et al.
Publicado: (2011)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

A hybrid model of complexity estimation: Evidence from Russian legal texts
por: Blinova, Olga, et al.
Publicado: (2022)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2020)

The Effectiveness of Russian Government Policy to Support SMEs in the COVID-19 Pandemic
por: Razumovskaia, Elena, et al.
Publicado: (2020)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children
por: Claeys, Carine, et al.
Publicado: (2019)

The Korean Influenza National Immunization Program: History and Present Status
por: Yun, Jae-Won, et al.
Publicado: (2017)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019
por: Seo, Jeongmin, et al.
Publicado: (2022)

Novel strain of influenza virus is useful in inactivated vaccine production
Publicado: (1991)

Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population
por: Tavares, Diana, et al.
Publicado: (2022)

Analysis of Avian Influenza (H5N5) Viruses Isolated in the Southwestern European Part of the Russian Federation in 2020–2021
por: Zinyakov, Nikolay, et al.
Publicado: (2022)

The Russian vaccine for COVID-19
por: Burki, Talha Khan
Publicado: (2020)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
por: Ni, Yawei, et al.
Publicado: (2018)

Update of inactivated equine influenza vaccine strain in Japan
por: GAMOH, Koichiro, et al.
Publicado: (2017)

Sex-specific differences of humoral immunity and transcriptome diversification in older adults vaccinated with inactivated quadrivalent influenza vaccines
por: Yang, Jing, et al.
Publicado: (2021)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
por: Herrera-Rodriguez, José, et al.
Publicado: (2019)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation
por: Shcherbik, Svetlana, et al.
Publicado: (2015)

National trends in incidence and geographic distribution of melanoma and keratinocyte carcinoma in the Russian Federation
por: Muntyanu, Anastasiya, et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation
por: Laberko, Alexandra, et al.
Publicado: (2023)

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
por: Geeraedts, Felix, et al.
Publicado: (2008)

Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats
por: Velineni, Sridhar, et al.
Publicado: (2019)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
por: Kon, Theone C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2tkhio32p25lm64b0tf27s381h